News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan
September 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo, Sept 21, 2006 (JCN) - Shionogi & Co., Ltd. and Nippon Kayaku Co., Ltd. today announced the release of Cetrotide (generic name: Cetrorelix acetate), indicated for the prevention of premature ovulation.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
MORE ON THIS TOPIC
Approvals
Boehringer Wins Speedy Lung Cancer Approval Under Commissioner’s Priority Program
February 27, 2026
·
2 min read
·
Tristan Manalac
FDA
Prasad Under Probe for Promoting Workplace Toxicity, Staffers Say
February 27, 2026
·
2 min read
·
Tristan Manalac
Policy
FDA Policy Tracker 2026: One-Trial Drug Applications, Guidelines for Personalized Therapies
February 27, 2026
·
7 min read
·
Heather McKenzie
Regulatory
Makary Defends FDA’s Decision-Making Amid Contentious Rare Disease Rejections
February 27, 2026
·
2 min read
·
Tristan Manalac
